Zhang 2006.
Methods | Six‐week, (likely) randomised study. |
Participants | In‐ and out‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 30 participants. Maprotyline: 30 participants. Citalopram dose range: 10‐40 mg/day (mean dose: 21.90 SD:6.93). Maprotyline dose range: 25‐200 mg/day (mean dose: 141.52 SD: 30.4). |
Outcomes | Change in Hamilton Depression Rating Scale 17 Item (HDRS‐17) score from baseline to endpoint, number of patients who responded to treatment. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |